{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T07:43:52Z","timestamp":1770536632004,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aims<\/jats:title>\n                <jats:p>The use of angiotensin-converting enzyme inhibitors (ACEi) or angiotensin II-receptor blockers (ARBs) post-myocardial infarction (MI) is supported by\u00a0evidence based on trials performed in the thrombolysis era. This was prior to primary percutaneous coronary intervention (PCI) being routine practice, and with little direct evidence for the use of these medications in patients with preserved left ventricular (LV) function. This study sought to determine whether there is an association between ACEi\/ARB use after PCI for acute coronary syndrome (ACS) and long-term all-cause mortality, with a particular focus on patients with preserved LV function.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This multicentre, observational study evaluated prospectively collected data of 21,388 patients (&gt;\u200918\u00a0years old) that underwent PCI for NSTEMI and STEMI between 2005 and 2018, and were alive at 30\u00a0day follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 83.8% of patients were using ACEi\/ARBs. Kaplan\u2013Meier analysis demonstrated ACEi\/ARB use was associated with a significantly lower mortality in the entire cohort (15.0 vs. 22.7%; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) with a mean follow-up of 5.58\u00a0years; and independently associated with 24% lower mortality by Cox proportional hazards modelling (HR 0.76, CI 0.67\u20130.85, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). ACEi\/ARB therapy was also associated with significantly lower mortality in patients with reduced or preserved LV function, with greater survival benefit with worse LV dysfunction.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>ACEi\/ARB therapy post-PCI is associated with significantly lower long-term mortality in patients with reduced and preserved LV function. These findings provide contemporary evidence for using these agents in the current era of routine primary PCI, including those with preserved EF.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00392-021-01985-x","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T12:07:10Z","timestamp":1642680430000},"page":"776-786","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Role of renin\u2013angiotensin system antagonists on long-term mortality post-percutaneous coronary intervention in reduced and preserved ejection fraction"],"prefix":"10.1007","volume":"111","author":[{"given":"Hamish C.","family":"Prosser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kah Yong","family":"Peck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diem","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaya","family":"Chandrasekhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew E.","family":"Ajani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Oqueli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher M.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jithin K.","family":"Sajeev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew W.","family":"Teh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"issue":"14","key":"1985_CR1","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/CIRCULATIONAHA.114.013042","volume":"131","author":"J Iqbal","year":"2015","unstructured":"Iqbal J, Zhang YJ, Holmes DR et al (2015) Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up. Circulation 131(14):1269\u20131277","journal-title":"Circulation"},{"issue":"41","key":"1985_CR2","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1093\/eurheartj\/ehx515","volume":"38","author":"K Szummer","year":"2017","unstructured":"Szummer K, Wallentin L, Lindhagen L et al (2017) Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995\u20132014. Eur Heart J 38(41):3056\u20133065","journal-title":"Eur Heart J"},{"key":"1985_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/imj.14750","author":"MB Yudi","year":"2020","unstructured":"Yudi MB, Farouque O, Andrianopoulos N et al (2020) Prognostic Significance of Suboptimal Secondary Prevention Pharmacotherapy After Acute Coronary Syndromes. Intern Med J. https:\/\/doi.org\/10.1111\/imj.14750","journal-title":"Intern Med J"},{"issue":"4","key":"1985_CR4","first-page":"e362","volume":"127","author":"PT O'Gara","year":"2013","unstructured":"O\u2019Gara PT, Kushner FG, Ascheim DD et al (2013) 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation 127(4):e362-425","journal-title":"Circulation"},{"issue":"9","key":"1985_CR5","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.hlc.2016.06.789","volume":"25","author":"DP Chew","year":"2016","unstructured":"Chew DP, Scott IA, Cullen L et al (2016) National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of acute coronary syndromes 2016. Heart Lung Circ 25(9):895\u2013951","journal-title":"Heart Lung Circ"},{"issue":"2","key":"1985_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B, James S, Agewall S et al (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39(2):119\u2013177","journal-title":"Eur Heart J"},{"issue":"13","key":"1985_CR7","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1093\/eurheartj\/ehm161","volume":"28","author":"JP Task Force","year":"2007","unstructured":"Task Force JP, Bassand CWH et al (2007) Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 28(13):1598\u20131660","journal-title":"Eur Heart J"},{"issue":"25","key":"1985_CR8","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1161\/CIR.0000000000000133","volume":"130","author":"EA Amsterdam","year":"2014","unstructured":"Amsterdam EA, Wenger NK, Brindis RG et al (2014) 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation 130(25):2354\u20132394","journal-title":"Circulation"},{"issue":"5","key":"1985_CR9","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/ccd.26679","volume":"88","author":"IY Elgendy","year":"2016","unstructured":"Elgendy IY, Kumbhani DJ, Mahmoud AN et al (2016) Routine invasive versus selective invasive strategies for Non-ST-elevation acute coronary syndromes: an updated meta-analysis of randomized trials. Catheter Cardiovasc Interv 88(5):765\u2013774","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"1985_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.hlc.2005.08.001","volume":"15","author":"AE Ajani","year":"2006","unstructured":"Ajani AE, Szto G, Duffy SJ et al (2006) The foundation and launch of the Melbourne Interventional Group: a collaborative interventional cardiology project. Heart Lung Circ 15(1):44\u201347","journal-title":"Heart Lung Circ"},{"issue":"9","key":"1985_CR11","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/heartjnl-2020-316605","volume":"107","author":"KY Peck","year":"2021","unstructured":"Peck KY, Andrianopoulos N, Dinh D et al (2021) Role of beta blockers following percutaneous coronary intervention for acute coronary syndrome. Heart 107(9):728\u2013733","journal-title":"Heart"},{"key":"1985_CR12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.atherosclerosis.2018.11.030","volume":"280","author":"YH Kim","year":"2019","unstructured":"Kim YH, Her AY, Jeong MH et al (2019) Impact of renin-angiotensin system inhibitors on long-term clinical outcomes in patients with acute myocardial infarction treated with successful percutaneous coronary intervention with drug-eluting stents: comparison between STEMI and NSTEMI. Atherosclerosis 280:166\u2013173","journal-title":"Atherosclerosis"},{"issue":"12","key":"1985_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.repc.2016.07.003","volume":"35","author":"MC Gonzalez-Cambeiro","year":"2016","unstructured":"Gonzalez-Cambeiro MC, Lopez-Lopez A, Abu-Assi E et al (2016) Mortality benefit of long-term angiotensin-converting enzyme inhibitors or angiotensin receptor blockers after successful percutaneous coronary intervention in non-ST elevation acute myocardial infarction. Rev Port Cardiol 35(12):645\u2013653","journal-title":"Rev Port Cardiol"},{"issue":"1","key":"1985_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.amjcard.2014.03.055","volume":"114","author":"M Hara","year":"2014","unstructured":"Hara M, Sakata Y, Nakatani D et al (2014) Comparison of 5-year survival after acute myocardial infarction using angiotensin-converting enzyme inhibitor versus angiotensin II receptor blocker. Am J Cardiol 114(1):1\u20138","journal-title":"Am J Cardiol"},{"issue":"10","key":"1985_CR15","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1056\/NEJM199209033271001","volume":"327","author":"MA Pfeffer","year":"1992","unstructured":"Pfeffer MA, Braunwald E, Moye LA, The SAVE Investigators et al (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 327(10):669\u2013677","journal-title":"N Engl J Med"},{"issue":"25","key":"1985_CR16","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","volume":"333","author":"L Kober","year":"1995","unstructured":"Kober L, Torp-Pedersen C, Carlsen JE et al (1995) A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 333(25):1670\u20131676","journal-title":"N Engl J Med"},{"issue":"8875","key":"1985_CR17","first-page":"821","volume":"342","author":"The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators","year":"1993","unstructured":"The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators (1993) Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342(8875):821\u2013828","journal-title":"Lancet"},{"issue":"3","key":"1985_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"S Yusuf","year":"2000","unstructured":"Heart Outcomes Prevention Evaluation Study Investigators, Yusuf S, Sleight P et al (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342(3):145\u2013153","journal-title":"N Engl J Med"},{"issue":"9386","key":"1985_CR19","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","volume":"362","author":"KM Fox","year":"2003","unstructured":"Fox KM, I.n.v.e.s.t.i.g.a.t.o.r.s. EUROPA (2003) Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362(9386):782\u2013788","journal-title":"Lancet"},{"issue":"20","key":"1985_CR20","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1056\/NEJMoa042739","volume":"351","author":"E Braunwald","year":"2004","unstructured":"Braunwald E, Domanski MJ, Fowler SE et al (2004) Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med 351(20):2058\u20132068","journal-title":"N Engl J Med"},{"issue":"6","key":"1985_CR21","doi-asserted-by":"publisher","first-page":"E20","DOI":"10.1016\/S0002-8703(03)00443-5","volume":"146","author":"J Kondo","year":"2003","unstructured":"Kondo J, Sone T, Tsuboi H et al (2003) Effects of low-dose angiotensin II receptor blocker candesartan on cardiovascular events in patients with coronary artery disease. Am Heart J 146(6):E20","journal-title":"Am Heart J"},{"issue":"4","key":"1985_CR22","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.amjcard.2015.05.007","volume":"116","author":"A Parashar","year":"2015","unstructured":"Parashar A, Agarwal S, Krishnaswamy A et al (2015) Renin-angiotensin system antagonists in patients without left ventricular dysfunction after percutaneous intervention for ST-segment elevation myocardial infarction. Am J Cardiol 116(4):508\u2013514","journal-title":"Am J Cardiol"},{"issue":"2","key":"1985_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/0003319719884187","volume":"71","author":"YH Kim","year":"2020","unstructured":"Kim YH, Her AY, Jeong MH et al (2020) ACE inhibitors versus ARBs in patients with NSTEMI with preserved LV systolic function who underwent PCI with new generation drug-eluting stents. Angiology 71(2):139\u2013149","journal-title":"Angiology"},{"key":"1985_CR24","doi-asserted-by":"publisher","first-page":"g6650","DOI":"10.1136\/bmj.g6650","volume":"349","author":"JH Yang","year":"2014","unstructured":"Yang JH, Hahn JY, Song YB et al (2014) Angiotensin receptor blocker in patients with ST segment elevation myocardial infarction with preserved left ventricular systolic function: prospective cohort study. BMJ 349:g6650","journal-title":"BMJ"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-021-01985-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-021-01985-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-021-01985-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T16:07:12Z","timestamp":1656518832000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-021-01985-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["1985"],"URL":"https:\/\/doi.org\/10.1007\/s00392-021-01985-x","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,20]]},"assertion":[{"value":"29 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}